Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Noonan Syndrome in Finland
Total 0 results
Nothing found
Sponsors and Collaborators
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
GFI
Mª Victoria Maestre Sanchez
Nacuity Pharmaceuticals, Inc.
RMIT University, Melbourne, Australia
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Agency for Science, Technology and Research
iCAD
Alma Lasers Inc.
Neurophth Therapeutics Inc
ASST Cremona, Cremona
Eurofins Genoma
Hospital Durand, Argentina
Kupfer, David J., M.D.
Aptis Medical
Apollo Neuroscience, Inc.
Hospital ASEPEYO Sant Cugat
Korean Society of Spine Surgery
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Everett Meyer
View Full List
Medical Conditions
Recurrent Clear Cell Sarcoma of Soft Tissue
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Scleredema
Gastric Cancer Stage IIIB-IIIC
Fever
Luteal Phase Support
RISS Stage III Plasma Cell Myeloma
Chronic Constipation Symptoms
Immune-Mediated Inflammatory Disease
Splenic Trauma
Disorder of Fluid Balance
Corneal Cross-Linking
Rheumatoid Arthritis(RA)
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Major Liver Surgery
Metachronous Adenoma
Treatment Decisions
The Strength Properties of the Aorta in Vitro
Dienogest
T-LGL Leukemia
View Full List
Drug Interventions
OnabotulinumtoxinA
Midazolam
Capecitabine/cisplatin
MLN2480
THC
Fospropofol disodium, propofol
Anticholinergic
Desvenlafaxine
Capecitabine and IMRT (if randomized to this arm)
Camptosar
RDX227675
Standard of care (SOC) for COVID-19
TPN-101
GLPG1837 multiple ascending doses
Olopatadine
Intravenous Formulation of PD-0332991
Intravenous deferiprone
Letrozole
PD-1/PD-L1 inhibitor
Oxycodone/acetaminophen 5/325 mg
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Bulgaria
Contract Research Organizations in Colombia
Contract Research Organizations in Croatia
Contract Research Organizations in Czech Republic
Contract Research Organizations in Iran
Contract Research Organizations in Ireland
Contract Research Organizations in Israel
Contract Research Organizations in Kenya
Contract Research Organizations in Pakistan
Contract Research Organizations in Peru
Contract Research Organizations in Portugal
Contract Research Organizations in Ukraine
CRO list by country
CROs in Morocco
4Clinics
SGS
"Gaya Pharma" by Morocco Africa Health & Pharma (MAHP)
MCT
All CROs in Morocco
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe